Chou Associates Management’s GSK GSK Stock Holding History

Chou Associates Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-14,400	Closed	-$347K	–	29
2016 Q4	$347K	Hold	14,400	–	–	0.11%	27
2016 Q3	$383K	Hold	14,400	–	–	0.14%	25
2016 Q2	$384K	Hold	14,400	–	–	0.15%	25
2016 Q1	$366K	Hold	14,400	–	–	0.12%	24
2015 Q4	$364	Hold	14,400	–	–	0.08%	23
2015 Q3	$344K	Hold	14,400	–	–	0.12%	23
2015 Q2	$374K	Hold	14,400	–	–	0.11%	23
2015 Q1	$413K	Hold	14,400	–	–	0.11%	23
2014 Q4	$386K	Hold	14,400	–	–	0.1%	22
2014 Q3	$750K	Hold	14,400	–	–	0.19%	20
2014 Q2	$514K	Hold	14,400	–	–	0.14%	20
2014 Q1	$484K	Hold	14,400	–	–	0.13%	19
2013 Q4	$478K	Buy	+14,400	New	+$934K	0.14%	21

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Chou Associates Management's GSK Position: Q1 2017 in Review

Chou Associates Management sold out of GSK (GSK) in Q1 2017, closing a stake of 14,400 shares — an estimated $347K sold.

Chou Associates Management first reported a position in GSK in Q4 2013 and held it in 13 quarters. The position peaked at $750K in Q3 2014. 787 funds tracked by Wall St. Rank hold GSK as of Q1 2017.

Chou Associates Management reported no remaining GSK position as of Q1 2017 after selling out during the quarter.
Chou Associates Management sold 14,400 GSK shares in Q1 2017, an estimated $347K.
Chou Associates Management first reported a position in GSK in Q4 2013 and held it in 13 quarters.
Chou Associates Management's GSK position peaked at $750K in Q3 2014.
787 funds tracked by Wall St. Rank held GSK as of Q1 2017.

Based on Chou Associates Management's 13F filing for Q1 2017, filed 12 May 2017.